Status:
COMPLETED
Assessing the Effects of the Muse Meditation System on Cognition and Well-being
Lead Sponsor:
Western University, Canada
Collaborating Sponsors:
InteraXon, Inc.
Cambridge Brain Sciences
Conditions:
Cognitive Change
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Interaxon markets a head-worn EEG biofeedback device ('Muse') to encourage and aid effective meditation and sleep. This device has been previously shown to improve workplace wellness, fatigue and qual...
Detailed Description
Meditation is a non-invasive technique that has recently gained significant popularity for its ability to effect positive change on the mind and body. Even a brief (4 sessions) meditation training int...
Eligibility Criteria
Inclusion
- The study will be open only to all Hatch Inc employees in Canada.
Exclusion
- If participants do not own a smart phone
- \-
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04790929
Start Date
May 1 2021
End Date
December 1 2022
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Western University
London, Canada